Free Trial
→ The stealth altcoin the financial world is underestimating (From Crypto 101 Media) (Ad)tc pixel Free TARS Stock Alerts

Tarsus Pharmaceuticals (TARS) SEC Filings & 10K Form

Tarsus Pharmaceuticals logo
$58.58 +0.42 (+0.72%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$58.58 +0.01 (+0.01%)
As of 08/29/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Tarsus Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
08/14/2025
7:08 AM		RTW INVESTMENTS, LP (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
08/11/2025
11:43 AM		Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/16/2025
2:07 PM		Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2025
3:50 PM		Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
9:21 AM		Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2025
10:27 AM		MORGAN STANLEY (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
05/01/2025
3:10 PM		Tarsus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/28/2025
3:09 PM		Tarsus Pharmaceuticals (Filer)
Form ARS
04/24/2025
8:12 AM		BlackRock, Inc. (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
03/26/2025
3:47 PM		Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:35 PM		Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
8:49 PM		Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
8:48 PM		Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
8:48 PM		Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
8:48 PM		Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
8:49 PM		Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
8:49 PM		Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:29 PM		Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:30 PM		Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:35 PM		Tarsus Pharmaceuticals (Subject)
Whitfield Dianne C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:18 PM		Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:21 PM		Tarsus Pharmaceuticals (Subject)
Wahl Bryan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:11 PM		Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:24 PM		Tarsus Pharmaceuticals (Subject)
Wahl Bryan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:27 PM		Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:22 PM		Tarsus Pharmaceuticals (Subject)
Whitfield Dianne C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:23 PM		Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:12 PM		Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:12 PM		Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
8:38 PM		Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:39 PM		Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:39 PM		Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:39 PM		Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:40 PM		Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:40 PM		Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
3:26 PM		Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
3:26 PM		Tarsus Pharmaceuticals (Subject)
Wahl Bryan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
3:31 PM		Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
3:20 PM		Tarsus Pharmaceuticals (Subject)
Whitfield Dianne C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2025
3:37 PM		Tarsus Pharmaceuticals (Filer)
Form 424B5
03/13/2025
3:40 PM		Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Retire Comfortably with These New Monthly Income ETFs? (Ad)

Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns just aren’t enough anymore. But what if you could reach your Freedom Number—the monthly income that makes retirement secure—using far less money than you thought possible? That’s exactly what Kelly G. discovered. She calls it “life-changing,” saying the income just keeps growing and that early retirement suddenly looks real. This strategy was once reserved for the ultra-wealthy, but it’s now available to everyday investors.tc pixel

Click here to watch the free presentation and learn how to calculate your personal Freedom Number—an
03/12/2025
3:26 PM		Tarsus Pharmaceuticals (Filer)
Form 424B5
03/07/2025
3:17 PM		Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:17 PM		Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:18 PM		Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:19 PM		Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:19 PM		Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
6:07 AM		Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
11:22 AM		Cowen Financial Products LLC (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/17/2025
4:08 PM		Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:30 AM		Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
4:03 PM		Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
2:05 PM		Cormorant Asset Management, LP (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13G/A
11/13/2024
3:06 PM		Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:40 PM		Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
9:26 AM		Frazier Life Sciences IX, L.P. (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13G/A
11/05/2024
3:06 PM		Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
1:00 PM		Tarsus Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/21/2024
3:11 PM		BlackRock, Inc. (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13G/A
10/02/2024
4:27 PM		Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:52 PM		Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:TARS) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners
Retire Comfortably with These New Monthly Income ETFs?
Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...
Investors Alley | Sponsoredtc pixel
One tiny company just cracked Google’s $19B problem
An MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...
True Market Insiders | Sponsoredtc pixel
Warren Buffett Issues Cryptic Warning on U.S. Dollar
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...
Banyan Hill Publishing | Sponsoredtc pixel
A Major Economic Change Is Happening Now
Louis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...
InvestorPlace | Sponsoredtc pixel
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...
The Oxford Club | Sponsoredtc pixel
“HELIOS”: My No. 1 Investment of the 2020s
A mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...
Stansberry Research | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
BREAKING: Meta, Apple and NASA rush to invest in new "E.I." tech
Big Tech and even NASA are racing to back a breakthrough known as “E.I. Tech,” set to launch September 1st. Ex...
Behind the Markets | Sponsoredtc pixel